HARMONY BIOSCIENCES HOLDINGS, INC. Shares Outstanding (Cover Page)
HARMONY BIOSCIENCES HOLDINGS, INC. (HRMY) had Shares Outstanding (Cover Page) of 58.24 million shares as of 2026-07-31, per its 10-Q filed 2026-08-04.
Financial Statements › Notes › Cover Page
dei:EntityCommonStockSharesOutstanding · last filed 2026-08-04
- 2026-07-31: Entity Common Stock, Shares Outstanding 58.24M shares.
- 2026-05-05: Entity Common Stock, Shares Outstanding 57.89M shares.
- 2026-02-20: Entity Common Stock, Shares Outstanding 57.84M shares.
- 2025-10-31: Entity Common Stock, Shares Outstanding 57.60M shares.
| Period end | Entity Common Stock, Shares Outstanding |
|---|---|
| 2026-07-31 | 58.24M shares 10-Q · filed 2026-08-04 |
| 2026-05-05 | 57.89M shares 10-Q · filed 2026-05-07 |
| 2026-02-20 | 57.84M shares 10-K · filed 2026-02-24 |
| 2025-10-31 | 57.60M shares 10-Q · filed 2025-11-04 |
| 2025-08-01 | 57.53M shares 10-Q · filed 2025-08-05 |
| 2025-05-02 | 57.42M shares 10-Q · filed 2025-05-06 |
| 2025-02-21 | 57.35M shares 10-K · filed 2025-02-25 |
| 2024-10-25 | 57.03M shares 10-Q · filed 2024-10-29 |
| 2024-08-02 | 56.83M shares 10-Q · filed 2024-08-06 |
| 2024-04-26 | 56.79M shares 10-Q · filed 2024-04-30 |
| 2024-02-16 | 56.77M shares 10-K/A · filed 2024-02-28 |
| 2023-10-27 | 58.57M shares 10-Q · filed 2023-10-31 |
| 2023-07-28 | 60.00M shares 10-Q · filed 2023-08-01 |
| 2023-04-28 | 59.95M shares 10-Q · filed 2023-05-02 |
| 2023-02-17 | 59.62M shares 10-K · filed 2023-02-21 |
| 2022-10-28 | 59.32M shares 10-Q · filed 2022-11-01 |
| 2022-07-29 | 59.16M shares 10-Q · filed 2022-08-02 |
| 2022-04-29 | 59.05M shares 10-Q · filed 2022-05-03 |
| 2022-02-25 | 58.87M shares 10-K · filed 2022-02-28 |
| 2021-11-05 | 58.47M shares 10-Q · filed 2021-11-09 |
| 2021-08-05 | 57.01M shares 10-Q · filed 2021-08-10 |
| 2021-05-04 | 56.90M shares 10-Q · filed 2021-05-11 |
| 2021-03-15 | 56.89M shares 10-K · filed 2021-03-25 |
| 2020-11-09 | 56.89M shares 10-Q · filed 2020-11-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Vera Therapeutics, Inc. (VERA) | United States | $2.402B | -7.67 |
| uniQure N.V. (QURE) | $2.416B | -4.93 | |
| SELLAS Life Sciences Group, Inc. (SLS) | United States | $2.420B | -91.87 |
| Mineralys Therapeutics, Inc. (MLYS) | United States | $2.353B | -6.82 |
| Viridian Therapeutics, Inc.\DE (VRDN) | United States | $2.342B | -5.38 |
| Nurix Therapeutics, Inc. (NRIX) | United States | $2.457B | -5.39 |
| SUPERNUS PHARMACEUTICALS, INC. (SUPN) | United States | $2.517B | -24.63 |
| Immunome Inc. (IMNM) | United States | $2.538B | -9.45 |
| Disc Medicine, Inc. (IRON) | United States | $2.553B | -11.40 |
| Zai Lab Ltd (ZLAB) | $2.241B | -113.34 |